Benjamin Edwards Inc’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$922K Buy
9,118
+397
+5% +$41.1K 0.01% 836
2026
Q1
$844K Buy
8,721
+713
+9% +$73.1K 0.01% 817
2025
Q4
$850K Buy
8,008
+112
+1% +$13K 0.01% 770
2025
Q3
$1M Buy
7,896
+2,767
+54% +$329K 0.01% 686
2025
Q2
$629K Buy
5,129
+380
+8% +$43.4K 0.01% 778
2025
Q1
$481K Sell
4,749
-1,796
-27% -$175K 0.01% 795
2024
Q4
$605K Buy
6,545
+247
+4% +$24.3K 0.01% 768
2024
Q3
$609K Buy
6,298
+1,707
+37% +$153K 0.01% 732
2024
Q2
$394K Buy
4,591
+9
+0.2% +$755 0.08% 251
2024
Q1
$378K Buy
4,582
+697
+18% +$51K 0.08% 255
2023
Q4
$259K Buy
3,885
+142
+4% +$9.2K 0.06% 278
2023
Q3
$251K Buy
3,743
+2,656
+244% +$183K 0.06% 249
2023
Q2
$74K Buy
1,087
+512
+89% +$32.1K 0.02% 424
2023
Q1
$31K Buy
575
+338
+143% +$19.7K 0.01% 506
2022
Q4
$14K Buy
+237
New +$12.9K ﹤0.01% 549

Other funds holding EHC

Benjamin Edwards Inc's EHC Position: Q2 2026 in Review

Benjamin Edwards Inc increased its Encompass Health (EHC) stake by 4.6% in Q2 2026, buying an estimated $41.1K and bringing the position to 9,118 shares worth $922K. The position accounts for 0.01% of the portfolio, ranked #836.

Benjamin Edwards Inc first reported a position in EHC in Q4 2022 and has held it in 15 quarters since. The position peaked at $1M in Q3 2025. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Benjamin Edwards Inc held 9,118 shares of Encompass Health worth $922K as of Q2 2026.
  • Benjamin Edwards Inc bought 397 Encompass Health shares in Q2 2026, an estimated $41.1K.
  • Encompass Health made up 0.01% of Benjamin Edwards Inc's portfolio in Q2 2026, its #836 holding.
  • Benjamin Edwards Inc first reported a position in Encompass Health in Q4 2022 and has held it in 15 quarters since.
  • Benjamin Edwards Inc's Encompass Health position peaked at $1M in Q3 2025.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.